Aranthan Jones's most recent trade in Vanda Pharmaceuticals Inc was a trade of 16,824 Common Stock done at an average price of $16.5 . Disclosure was reported to the exchange on Sept. 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 15 Sep 2021 | 16,824 | 81,980 (0%) | 0% | 16.5 | 277,394 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.32 per share. | 15 Sep 2021 | 7,842 | 98,804 (0%) | 0% | 11.3 | 88,771 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 7,842 | 47,158 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 4,277 | 33,224 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 15 Sep 2021 | 4,277 | 90,962 (0%) | 0% | 12.3 | 52,479 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 26 Jul 2021 | 7,250 | 86,685 (0%) | 0% | 19.7 | 142,776 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 17.72 per share. | 15 Mar 2021 | 18,000 | 93,935 (0%) | 0% | 17.7 | 319,010 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.32 per share. | 15 Mar 2021 | 15,000 | 111,935 (0%) | 0% | 11.3 | 169,800 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 15,000 | 55,000 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 02 Mar 2021 | 3,865 | 96,935 (0%) | 0% | 18.0 | 69,717 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 61,200 | 61,200 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,800 | 101,287 (0%) | 0% | - | Common Stock | |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 24 Feb 2021 | 22,986 | 100,800 (0%) | 0% | 20.0 | 460,033 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 24 Feb 2021 | 22,499 | 123,786 (0%) | 0% | 12.3 | 276,063 | Common Stock |
| Vanda Pharmaceuticals Inc | Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 22,499 | 37,501 | - | - | Employee Stock Option (Right to Buy) |